SOM DATT FINANCE CORPORATION LTD.

Crescentis Capital Ltd announced the resignation of Mr. Sai Kumar Subramanya, Head – Business Development (AVP) and Senior Management Personnel. The resignation is effective from July 16, 2026, and is due to Mr. Subramanya pursuing another professional opportunity overseas. The company has submitted the necessary disclosures as per SEBI regulations. Mr. Subramanya expressed gratitude for his tenure.

Crescentis Capital Ltd announced a share transfer between its promoters, Dr. Bhaskara Rao Bollineni and Mr. Bhavanam Ruthvik Reddy. Dr. Bollineni gifted 3,00,000 equity shares, representing 1.76% of the total capital, to Mr. Reddy via an off-market transaction. This re-distribution within the promoter group results in Dr. Bollineni's holding decreasing from 68.80% to 67.04%, while Mr. Reddy's holding increases from 6.17% to 7.94%. The aggregate shareholding of the promoter and promoter group remains unchanged.

Crescentis Capital Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in connection with the consideration and declaration of the Unaudited Financial Results for the quarter ended June 30, 2026. The trading window will remain shut from July 1, 2026, until 48 hours after the official declaration of these financial results. The company has advised all insiders and designated individuals to refrain from trading in its securities during this period, adhering to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Crescentis Capital Ltd announced an inter-se transfer of equity shares within its promoter group. Dr. Bhaskara Rao Bollineni gifted 3,00,000 equity shares, representing 1.76% of the paid-up capital, to Mr. Bhavanam Ruthvik Reddy. This off-market transaction occurred on June 24, 2026. Following the gift, Dr. Bollineni's holding decreased from 68.80% to 67.04%, while Mr. Reddy's increased from 6.17% to 7.94%. The aggregate shareholding of the promoter group remains unchanged, with the transfer constituting a redistribution within the group. The disclosure is made pursuant to SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Crescentis Capital Ltd. has submitted a declaration under Regulation 33(3)(d) of the SEBI (LODR) Regulations, 2015, confirming that their Statutory Auditors, M/s. D.S. Talwar & Co., have issued an Audit Report with an unmodified opinion on the audited financial results for the year ended March 31, 2026. This submission rectifies an earlier oversight where a declaration under Regulation 33(2)(a) was incorrectly submitted. The company requests the exchange to take the updated declaration on record.

Crescentis Capital Ltd has re-appointed Mr. Subba Rao Veera Venkata Meka as Managing Director and Mr. Bhavanam Ruthvik Reddy as Whole Time Director & CEO for a further term of five years, effective September 12, 2026. The re-appointments, approved by the Board on May 29, 2026, are subject to shareholder approval at the upcoming General Meeting and other regulatory requirements. Mr. Meka has over four decades of experience in banking and financial services, while Mr. Reddy is related to Mr. Bhaskara Rao Bollineni.

Crescentis Capital Ltd has granted 5,00,000 stock options to Mr. Subba Rao Veera Venkata Meka, Managing Director, under the Crescentis Capital Limited Employees’ Stock Option Scheme, 2025 (“CCL ESOS 2025”). The grant was approved by the Nomination and Remuneration Committee and subsequently taken on record by the Board of Directors on May 29, 2026. The exercise price per option is ₹50. The options will vest in two tranches: 50% on May 28, 2027, and the remaining 50% on May 28, 2028.

Crescentis Capital Ltd's board approved the audited financial statements for the quarter and year ended March 31, 2026. The board also approved a proposal to raise up to ₹80 Crores through a rights issue of fully paid-up equity shares of ₹10 each to eligible shareholders, subject to necessary approvals. A Fund Raising Committee has been constituted to finalize the terms and conditions of the Rights Issue.

Crescentis Capital Ltd's board approved the audited financial statements for the quarter and financial year ended March 31, 2026. Additionally, they approved a proposal to raise up to ₹80 Crores through a rights issue of fully paid-up equity shares of Rs 10 each to eligible shareholders. The board has formed a Fund Raising Committee to finalize the terms and conditions of the Rights Issue, including the rights entitlement ratio, issue price, and record date, subject to necessary approvals.

Crescentis Capital Ltd has scheduled a Board of Directors meeting on May 29, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026. The board will also consider granting equity shares under ESOS to eligible employees and explore options for raising funds through various methods, subject to regulatory approvals. The trading window for dealing in the company's securities has been closed since April 1, 2026, and will remain closed until 48 hours after the results are made public.